Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide.
Golzand
Elena
E
Department of Neonatology, Division of Pediatrics, Hadassah University Hospital, Mt. Scopus, Jerusalem, Israel.
Bar-Oz
Benjamin
B
Arad
Ilan
I
D000280:Administration, Inhalation; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D045462:Endothelium-Dependent Relaxing Factors / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008297:Male; D009569:Nitric Oxide / Q000627:therapeutic use; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy*
D000959:Antihypertensive Agents; D045462:Endothelium-Dependent Relaxing Factors; D009569:Nitric Oxide; D011464:Epoprostenol